Windlas Biotech Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Consistent revenue growth over the past quarters, signaling strong demand for products.
Improved profit margins in the latest quarter reflect better cost management and operational efficiency.
Increased market share in key segments positions Windlas Biotech for future growth.

NEGATIVES

Rising input costs have impacted profitability, posing a risk to margins.
Slower growth in exports compared to domestic sales raises concerns about market diversification.
High debt levels could limit financial flexibility and investment in growth opportunities.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	144.79	152.67	162.21	171.28	175.15	187	195.02	210.09
Expenses	131.07	137.60	145.57	153.09	160.97	171.56	178.79	192.07
Operating Profit	13.72	15.07	16.64	18.19	14.18	15.45	16.23	18.02
Other Income	2.62	3.24	3.16	4.44	4.13	4.84	4.11	5.24
Interest	0.24	0.29	0.30	0.28	0.49	1.10	1.46	1.06
Depreciation	3.19	3.33	3.39	3.54	6.21	6.50	6.94	7.45
Profit Before Tax	16.34	18.31	19.81	22.63	18.31	20.29	20.34	23.26
Tax	4.28	4.28	4.71	5.64	4.83	4.63	4.76	5.59
Net Profit	12.07	14.03	15.10	16.99	13.48	15.66	15.58	17.66
Eps in Rs	5.79	6.75	7.26	8.17	6.47	7.49	7.45	8.43